Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03148080 · ClinicalTrials.gov registry record
Work Ability in Young Adult Cancer Survivors
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 214
- Enrollment target
NCT03148080: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03148080 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 214 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03148080 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 214 participants
- Enrollment target
Study Summary
To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.
Primary Outcome
Labor force participation will be summarized as employed, unemployed (not working, but looking for work), and not in labor force (not employed and not looking for work or active duty military).
Interventions
- OTHER Questionnaire Administration
- PROCEDURE Cognitive Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2022-07-29 |
What the finished NCT03148080 record still lists
NCT03148080 is an observational study that tracks outcomes without assigning an intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT03148080 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03148080 about?
NCT03148080 is a clinical study titled "Work Ability in Young Adult Cancer Survivors". To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.
What is the current status of trial NCT03148080?
This trial is currently completed. The enrollment target is 214 participants. The study started on 2018-03-13. Estimated completion is 2022-07-29.
What interventions are being tested in trial NCT03148080?
The interventions under investigation include: Questionnaire Administration (OTHER), Cognitive Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT03148080?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI